# Hiroaki Kitano

> Hiroaki Kitano is a seed investor at SoftBank Mobile backing Health Care and Fitness. See 8 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Fund: [SoftBank Mobile](https://shizune.co/investors/profile/softbank-mobile)
- Total investments: 8
- Last investment: May 2023
- Lead investor: 0%
- Last updated: Aug 2026
- LinkedIn: http://www.linkedin.com/pub/hiroaki-kitano/13/884/b63
- Website: https://www.sony.com/en/SonyInfo/CorporateInfo/executive/
- Facebook: https://www.facebook.com/hiroaki.kitano

Hiroaki Kitano is a seed investor at SoftBank Mobile focused on Health Care and Fitness. Senior Executive Vice President and CTO at Sony Group Corporation and President & CEO at Sony Computer Science Laboratories, Inc.. He attended Waseda University.

## Round sizes

| Stage | Round size |
| --- | --- |
| Seed | $3.3M–$43M |

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Health Care | 4 | 50% |
| Fitness | 2 | 25% |
| Medical | 2 | 25% |
| Wellness | 2 | 25% |
| Biotechnology | 2 | 25% |

24 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Seed | 3 | 38% |
| Angel | 3 | 38% |
| Funding Round | 1 | 13% |
| Debt Financing | 1 | 13% |

### Country

| Country | Investments | Share |
| --- | --- | --- |
| Japan | 4 | 50% |
| United States | 2 | 25% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| AnotherBall | AnotherBall is a blockchain startup that combines entertainment and blockchain. | $2.2M | Angel | May 16, 2023 |  |
| GPx | GPx is a biotech company that revolutionizes remote chronic disease management with bloodless blood tests. It is dedicated to transforming the standard of care of cardiorenal diseases and enabling patients to better understand their condition, much like the continuous glucose monitor has transformed diabetes care.The company was founded in 2020and is based in Boston, Massachusetts. | $3.3M | Seed | Sep 30, 2022 |  |
| Epistra | Epistra accelerates research and development in life sciences. |  | Angel | Oct 30, 2019 |  |
| SmarTrial | Activaid owns and operates a social data platform for patients with inflammatory bowel disease. It allows patients to support and exchange information within the patient community with the same disease; provide information necessary for new drug development and matching to clinical trials that suits them; and improve medical treatment. YasuakiHasebe founded Activaid in 2018. It has its headquarters in Tokyo in Japan. |  | Angel | Jun 13, 2019 |  |
| Integriculture | Integriculture makes cellular agriculture products to improve sustainability, food security, and reduce public health problems. The company offers a developed patented general-purpose large-scale cell culture system that can culture wide range of cells without external addition of expensive growth factors and provide consumers with affordable cleanmeat.Founded in 2015, Integriculture is headquartered in Tokyo, Japan. | $42.5M | Seed | May 25, 2018 |  |
| Genomelink | Genomelink is a platform where people discover more with their DNA data and help businesses build, market and do research with it. The best founders in consumer genomics with real experience in the industry for many years, including M3, Inc. ($13B valued Meditech in Japan), a founding member of the Japanese version of 23andMe, and leadbioinformatician and software engineer at a joint-venture between Illumina and Sony. Raised $4M for Seed Round from Berkeley SkyDeck, SONY, and top-tier Japanese VCs. Supported by Illumina Accelerator, Carlos Bustamante Lab at Stanford University among others. | $7.1M | Seed | Aug 22, 2017 |  |
| FiNC Technologies | FiNC Technologies is a health tech company specializing in AI-driven wellness solutions. Their platform combines data analysis, rich content, and social elements to assist users in logging, understanding, managing, and improving their health and wellness. It empowers individuals to achieve their health goals effectively by leveraging machinelearning and personalized coaching. | $5.3M | Debt Financing | Aug 24, 2015 |  |
| SBX Corporation | SBX Corporation specializes in leveraging artificial intelligence to drive major scientific discoveries aimed at improving the global state. With a focus on computer science, biology, and their applications in drug discovery and biomedicine, SBX employs a dynamic team of scientists and engineers. The company's mission is to create an engine ofscientific discovery, utilizing AI to push the boundaries of what is possible in science and technology. Through research collaboration projects and the development of innovative AI systems, SBX aims to contribute significantly to the scientific community and the betterment of the world. |  |  |  |  |

8 of 8 investments shown.

## Co-investors
- [500 Global](https://shizune.co/investors/profile/500-startups) — VC Fund, 1 deal together
- [Beyond Next Ventures](https://shizune.co/investors/profile/beyond-next-ventures) — VC Fund, 1 deal together
- [D4V](https://shizune.co/investors/profile/d4v) — VC Fund, 1 deal together
- [IDEO](https://shizune.co/investors/profile/ideo) — VC Fund, 1 deal together
- [Japanese Organization for Medical Device Development](https://shizune.co/investors/profile/japanese-organization-for-medical-device-development) — VC Fund, 1 deal together
- [M3.com](https://shizune.co/investors/profile/m3-com) — VC Fund, 1 deal together

## About SoftBank Mobile

VC Fund · Tokyo, Japan

one of the mobile phone company in japan.

3 contacts available at SoftBank Mobile.

| Name | Title | Profile |
| --- | --- | --- |
| Hiroaki Kitano | SVP | https://shizune.co/investors/profile/hiroaki-kitano |
| Masayoshi Son | Founder, CEO | https://shizune.co/investors/profile/masayoshi-son |
| Mukaikubo Aya | Deputy Manager | https://shizune.co/investors/profile/mukaikubo-aya |

## Similar investors

### Similar industry
- [SVG Ventures](https://shizune.co/investors/profile/svg-ventures) — VC Fund
- [SOSV](https://shizune.co/investors/profile/sosv) — VC Fund
- [Omnivore](https://shizune.co/investors/profile/omnivore-partners) — VC Fund

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund

### Similar country
- [Mitsubishi UFJ Capital](https://shizune.co/investors/profile/mitsubishi-ufj-capital) — VC Fund
- [SMBC Venture Capital](https://shizune.co/investors/profile/smbc-venture-capital) — VC Fund
- [Mizuho Capital](https://shizune.co/investors/profile/mizuho-capital) — VC Fund

## Featured in investor lists
- [Biotech Angel Investors](https://shizune.co/investors/biotech-angel-investors)
- [Health Care Investors in Japan](https://shizune.co/investors/health-care-investors-japan)
- [Food and Beverage Angel Investors in Asia](https://shizune.co/investors/food-and-beverage-angel-investors-asia)
- [Food and Beverage Investors in Japan](https://shizune.co/investors/food-and-beverage-investors-japan)
- [Food and Beverage Angel Investors in Japan](https://shizune.co/investors/food-and-beverage-angel-investors-japan)
- [Wellness Investors in Japan](https://shizune.co/investors/wellness-investors-japan)

## FAQ

### What does Hiroaki Kitano invest in?

Hiroaki Kitano invests primarily in Health Care, Fitness and Medical startups, most often at Seed and Angel stage. Most of the 8 investments tracked by Shizune back companies in Japan. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### What is Hiroaki Kitano's check size?

Hiroaki Kitano typically joins rounds of $3.3M–$43M at Seed. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Hiroaki Kitano participates in.

### When did Hiroaki Kitano last invest?

The most recent investment recorded for Hiroaki Kitano closed in May 2023. Shizune tracks 8 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co